Assignee
UCB PHARMA SA
BE·109 granted patents·42 pending applications·822 citations·filing 2002–2024
Top patents by PatentIndex Score
151 records- 0195US9315770B2Bacterial host strainUCB PHARMA SA·Filed 2015·Granted Apr 19, 2016·11 cites·20 claims
- 0295US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0394USD755956SCassette device for administering medicationUCB PHARMA SA·Filed 2015·Granted May 10, 2016·50 cites·1 claims
- 0494US9309327B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2013·Granted Apr 12, 2016·32 cites·7 claims
- 0594US9040048B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2012·Granted May 26, 2015·19 cites·11 claims
- 0694US9011856B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Apr 21, 2015·7 cites·30 claims
- 0794USD726902SCassette device for administering medicationUCB PHARMA SA·Filed 2012·Granted Apr 14, 2015·60 cites·1 claims
- 0894US8992911B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Mar 31, 2015·7 cites·17 claims
- 0993US7300765B2SC6 for diagnosis of cancersUCB PHARMA SA·Filed 2003·Granted Nov 27, 2007·93 cites·2 claims
- 1092US9493558B2Bacterial host strain comprising a mutant SPR gene and a wild-type TSP geneUCB PHARMA SA·Filed 2015·Granted Nov 15, 2016·5 cites·24 claims
- 1191US9550973B2Bacterial host strainUCB PHARMA SA·Filed 2016·Granted Jan 24, 2017·5 cites·25 claims
- 1291US9428570B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2013·Granted Aug 30, 2016·18 cites·22 claims
- 1391USD641078SMedical syringe with needle tip capUCB PHARMA SA·Filed 2008·Granted Jul 5, 2011·36 cites·1 claims
- 1490US8378073B2Process for attaching effector molecules to proteinsUCB PHARMA SA·Filed 2006·Granted Feb 19, 2013·10 cites·21 claims
- 1589US9828438B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2016·Granted Nov 28, 2017·7 cites·8 claims
- 1689US9493559B2Bacterial host strain expressing recombinant DsbC and having reduced Tsp activityUCB PHARMA SA·Filed 2015·Granted Nov 15, 2016·5 cites·26 claims
- 1789US8053562B2Modified antibody fragmentsUCB PHARMA SA·Filed 2006·Granted Nov 8, 2011·13 cites·12 claims
- 1889US7858122B2Extended release formulation of levetiracetamUCB PHARMA SA·Filed 2005·Granted Dec 28, 2010·18 cites·5 claims
- 1989US7745156B2Methods for diagnosis and treatment of epithelial-derived cancersUCB PHARMA SA·Filed 2007·Granted Jun 29, 2010·11 cites·17 claims
- 2089US7355011B2Biological productsUCB PHARMA SA·Filed 2003·Granted Apr 8, 2008·21 cites·5 claims
- 2189US2024209075A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB PHARMA SA·Filed 2023·Application pending·0 cites
- 2288US7419659B2Expression control using variable intergenic sequencesUCB PHARMA SA·Filed 2002·Granted Sep 2, 2008·17 cites·6 claims
- 2387US10100130B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2017·Granted Oct 16, 2018·5 cites·11 claims
- 2487US7402662B2Antibody molecules specific to human tumor necrosis factor alphaUCB PHARMA SA·Filed 2006·Granted Jul 22, 2008·12 cites·2 claims
- 2586US8986954B2DNA encoding function modifying Nav1.7 antibodiesUCB PHARMA SA·Filed 2014·Granted Mar 24, 2015·6 cites·6 claims
- 2686US8710054B2Fused thiazole derivatives as kinase inhibitorsUCB PHARMA SA·Filed 2012·Granted Apr 29, 2014·9 cites·6 claims
- 2786US7993864B2Assay for identifying antibody producing cellsUCB PHARMA SA·Filed 2003·Granted Aug 9, 2011·20 cites·17 claims
- 2886US7692028B22-oxo-1-pyrrolidine derivatives, processes for preparing them and their usesUCB PHARMA SA·Filed 2007·Granted Apr 6, 2010·5 cites·5 claims
- 2984US9387212B2Methods for treating Parkinson's diseaseUCB PHARMA SA·Filed 2013·Granted Jul 12, 2016·10 cites·12 claims
- 3084US7754447B2Methods for producing recombinant proteinsUCB PHARMA SA·Filed 2004·Granted Jul 13, 2010·21 cites·46 claims
- 3184US7678785B2Substituted aniline derivativesUCB PHARMA SA·Filed 2007·Granted Mar 16, 2010·7 cites·22 claims
- 3284US2024269274A1Treatment for bone diseasesUCB PHARMA SA·Filed 2024·Application pending·0 cites
- 3383US10189897B2Protein purificationUCB PHARMA SA·Filed 2015·Granted Jan 29, 2019·3 cites·20 claims
- 3483US9587227B2Bacterial host strain comprising a mutant spr gene and having reduced Tsp activityUCB PHARMA SA·Filed 2015·Granted Mar 7, 2017·2 cites·34 claims
- 3583US7910618B2Albumin-binding conjugates comprising a fatty acid and PEGUCB PHARMA SA·Filed 2005·Granted Mar 22, 2011·2 cites·15 claims
- 3683US7863316B2Extended release formulation of LevetiracetamUCB PHARMA SA·Filed 2006·Granted Jan 4, 2011·15 cites·21 claims
- 3783US7790720B2Compounds comprising an oxazole or thiazole moiety, processes for making them, and their usesUCB PHARMA SA·Filed 2006·Granted Sep 7, 2010·12 cites·31 claims
- 3882US10421816B2Multivalent antibodiesUCB PHARMA SA·Filed 2016·Granted Sep 24, 2019·2 cites·9 claims
- 3982US7521460B2Thienopyridone derivatives as kinase inhibitorsUCB PHARMA SA·Filed 2004·Granted Apr 21, 2009·17 cites·11 claims
- 4081US9957328B2Bacterial host strain expressing recombinant DSBCUCB PHARMA SA·Filed 2017·Granted May 1, 2018·1 cites·27 claims
- 4181US9951365B2Recombinant bacterial host cell for protein expressionUCB PHARMA SA·Filed 2013·Granted Apr 24, 2018·4 cites·21 claims
- 4281US9791462B2Compositions and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2015·Granted Oct 17, 2017·1 cites·2 claims
- 4381US7977464B2Antibody molecules specific to human tumour necrosis factor alphaUCB PHARMA SA·Filed 2008·Granted Jul 12, 2011·3 cites·22 claims
- 4481US7592455B2Bicyclic heteroaromatic compounds as kinase inhibitorsUCB PHARMA SA·Filed 2003·Granted Sep 22, 2009·16 cites·6 claims
- 4581US7563912B2Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analoguesUCB PHARMA SA·Filed 2006·Granted Jul 21, 2009·6 cites·7 claims
- 4681US7501437B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2007·Granted Mar 10, 2009·3 cites·24 claims
- 4780US9902768B2Sequence asymmetric modified IgG4 bispecific antibodiesUCB PHARMA SA·Filed 2013·Granted Feb 27, 2018·5 cites·37 claims
- 4880US9394361B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB PHARMA SA·Filed 2014·Granted Jul 19, 2016·4 cites·9 claims
- 4979US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 5078US11702468B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2019·Granted Jul 18, 2023·0 cites·2 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →